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ObjectivOs: El manejo de la artritis reumatoide (AR) implica grandes retos para 
los sistemas de salud, especialmente en países en vía de desarrollo, ya que exige la 
implementación de programas de atención integral para reducir el desgaste gradual, 
la complicación de síntomas y el impacto económico tanto a nivel familiar como 
del Estado. El objetivo del estudio fue construir una guía de intervención psicológica 
basada en la evidencia que facilite el ejercicio de psicólogos en la atención integral 
de pacientes diagnosticados con AR en Colombia. MetOdOlOgíAs: Se realizó una 
revisión sistemática de literatura y se formularon recomendaciones para el abordaje 
de factores psicológicos y sociales de la enfermedad a partir de la evidencia empírica 
hallada sobre la intervención psicológica para pacientes diagnosticados con AR. La 
inclusión de tales recomendaciones en la guía se logró a través de reuniones de 
consenso no estructurado con el grupo desarrollador; también fueron consideradas 
en el proceso las opiniones de expertos y de pacientes. Las recomendaciones fueron 
calificadas según los lineamientos de la Scottish Intercollegiate Guidelines Network 
(SIGN). ResultAdOs: Las prácticas recomendadas en esta guía se consolidaron en 
siete apartados: 1) psico-educación; 2) apoyo social; 3) estado de ánimo; 4) adher-
encia al tratamiento; 5) autoeficacia; 6) autocontrol - automanejo; y 7) manejo de 
dolor. La guía se encuentra lista para iniciar su validación e implementación en el 
ámbito clínico. cOnclusiOnes: Por primera vez, Colombia cuenta con una guía 
de intervención psicológica basada en la evidencia para la atención de pacientes 
con AR y el propósito final es que sea adoptada por el Sistema Nacional de Salud. 
El siguiente paso en el proceso de construcción de esta guía es su validación con 
expertos clínicos, pacientes, el Ministerio de Salud y otros actores del sistema de 
salud colombiano para hacer posible su diseminación y puesta en marcha.
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Objectives: To assess adverse events (AEs) and relapse rates in multiple sclerosis 
(MS) patients on Glatiramer Acetate (GA) treatment before and after the introduction 
of a purported generic GA (pgGA) in Mexico. MethOds: A pgGA was introduced 
in Mexico in January 2013. The dispensation decision of branded versus pgGA was 
made by each Pharmacy based on a predetermined national quota (40% pgGA in 
2013, 50% in 2014) and availability, allowing the same patient to receive both treat-
ments over time. Patient-reported data on AEs, relapses and pgGA or branded GA 
use were collected through branded GA’s Patient Support Program. Differences in 
outcomes during 2012 when only branded GA was available, and during February–
May of 2014 when mostly branded GA was dispensed (due to pgGA hold) were 
compared with outcomes in 2013 and during February–May in 2013, respectively 
(when both products were dispensed). Results: The total number of MS patients in 
the program during 2012, 2013 and 2014 were 1618, 1552, and 1755, respectively. The 
total number of AEs and relapses reported in 2013 were significantly higher (P< 0.05) 
than 2012. The total number of AEs and relapses in each month in 2013 (except in 1) 
was higher (AEs – 11 to 92, relapses – 1 to 13) than each of the corresponding 2012 
months (AEs – 4 to 26, relapses – 0 to 2). Comparing number of relapses adjusted 
by number of patients during February–May of 2014 to the same period in 2013, 
showed a decrease in relapses in this period in 2014 vs. 2013 (P< 0.035). Further 
research is needed to fully elucidate the underlying causes for the marked differ-
ences reported. cOnclusiOns: The observed increase in AEs and relapses in MS 
patients in Mexico raise questions about the interchangeability and comparability 
of pgGA to branded GA on treatment safety and efficacy.
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Objectives: Neisseria meningitidis is a leading cause of bacterial meningitis and 
septicemia in infants, young children and adolescents, with considerable morbidity 
and mortality and health system costs. We synthesized available data to estimate the 
cost associated with meningococcal disease in Brazil, Chile, Colombia, and Panama 
from the societal perspective. MethOds: National treatment guidelines were con-
sidered to establish treatment practices of meningococcal disease in each country. 
A combination of retrospective data collection techniques was used in the study, 
including structured interviews to physicians and primary caregivers, and review of 
patient medical records, and medical registers of hospitals, health centers and labo-
ratory centers. All cost components were based on 2014 prices and were converted 
to US dollars using the official exchange rate. Results: The economics of menin-
gococcal disease is complex and multifaceted. The country that reported the highest 
treatment cost of meningococcal disease was Panama, taking up 62% of the total 
cost across the three countries. This was followed by Colombia and Chile with both 
taking up to 22% and 16% of the total costs of meningococcal disease, respectively. 
Direct medical costs and, more specifically, hospital care costs took up the biggest 
proportion of the total cost of meningococcal disease in all three countries, rang-
ing from 63% to 72%, reflecting on the level of disease severity. Loss of productivity 
Objectives: There are no studies to our knowledge assessing, whether there are 
racial disparities related to total ankle arthroplasty (TAA) utilization and outcomes. 
Our objective was to study the racial disparities in total ankle arthroplasty (TAA) uti-
lization and outcomes. MethOds: We used the Nationwide Inpatient Sample (NIS) 
to study the time-trends. Race was categorized as White and Black. Utilization rates 
were calculated for the U.S. general population per 100,000. Hospital length of stay, 
discharge disposition and mortality after TAA were assessed. We used the Cochran 
Armitage trend test to assess time-trends from 1998 to 2011 and chi-square test to 
compare TAA utilization. We used analysis of variance or chi-squared test to compare 
the characteristics of Whites and Blacks undergoing TAA and logistic regression to 
compare mortality, length of stay and discharge to home vs medical facility. Results: 
The mean ages for Whites undergoing TAA were 62 years and for Blacks was 52 years. 
Significant racial disparities were noted in TAA utilization rates (/100,000) in 1998, 0.14 
in Whites vs. 0.07 in Blacks (p< 0.0001; 2-fold) and in 2011, 1.17 in Whites vs. 0.33 in 
Blacks (p< 0.0001; 4-fold). Racial disparities in TAA utilization increased significantly 
from 1998 to 2011 (p< 0.0001). There was a trend towards statistical significance in the 
length of hospital stay in Blacks vs. Whites (52.9% vs. 44.3% with length of hospital 
stay higher than the median; p= 0.08). Differences in the proportion discharged to 
an inpatient medical facility after TAA, 16% Blacks vs. 13% Whites, were not signifi-
cant (p= 0.47) cOnclusiOns: This study demonstrated significant racial disparities 
with lower TAA utilization and suboptimal outcomes in Blacks compared to Whites. 
Further studies are needed to understand the mediators of these disparities and to 
assess whether these mediators can be targeted to reduce racial disparities in TAA.
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ObjetivOs: estimar a prevalência da espondilite anquilosante para subsidiar para 
avaliações econômicas sobre a doença. MétOdOs: realizou-se uma revisão sis-
temática com estratégia de busca nas bases de dados Medline, via PUBMED, e The 
Cochrane Library no mês de março de 2014. A leitura dos títulos foi realizada em 
pares e as divergências dirimidas por consenso. Não foram aplicadas restrições 
quanto a idiomas e datas, sendo excluídos estudos que não eram transversais e 
àqueles que não apresentavam desfechos relacionados à prevalência da doença. A 
extração dos dados foi realizada por meio de formulário específico e revisada por um 
par antes de sua inclusão. A análise estatística foi realizada com auxílio do programa 
R 3.1.0. e para tal foi desenvolvido um gráfico de forest plot. ResultAdOs: foram 
encontrados 1.646, que após leitura de títulos foram selecionados 146, dos resumos 
26 e textos completos 14 estudos, sendo todos realizados fora do Brasil. A maio-
ria desses trabalhos (85,7%) foi desenvolvido em ambiente hospitalar. A amostra 
total foi de 266.194 participantes e a média ponderada obtida da prevalência foi de 
0,5649% (p< 0.001; IC: 95%), variando de 0,08% a 1,4%. Vale destacar que os méto-
dos utilizados para coletar a prevalência, assim como, os critérios de classificação 
da doença, foram bastante variados. Devido a essa grande heterogeneidade entre 
os estudos adotou-se, na análise estatística, a medida de efeito aleatório por ser 
mais apropriada e conservadora para esses casos. cOnclusões: De acordo com 
dados do estudo foi identificada elevada prevalência e dispersão da doença na 
população mundial, que impactam os orçamentos dos sistemas públicos de saúde. 
Considerando a importância da doença, e o impacto orçamentário de novos medi-
camentos são necessários mais estudos, especialmente no Brasil e na América do 
Sul uma vez que não foi detectado nenhum artigo que aborde o tema nesses países.
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Objectives: The study intended to assess the impact of educational intervention on 
knowledge of osteoporosis among female university students of Quetta. MethOds: 
This interventional study was conducted on female university students by using 
convenience sampling technique. A total of 163 female students were enrolled for 
the study, these are those female students who did not heard about the disease 
named as osteoporosis. These subjects were provided with a self-explanatory 
brochure that contain basic information regarding osteoporosis. The intervention 
was completely theoretical in nature. After two days interval participants were 
contacted again and asked to complete a pre-validated questionnaire containing 
20 questions related to osteoporosis knowledge. Descriptive analysis was used to 
demonstrate the demographic characteristics of the study population. Inferential 
statistics (Mann-Whitney U test and Kruskal Wallis tests and Wilcoxon mean rank 
test, p< 0.05) were used to assess the significance among study variables and to 
assess the impact of educational intervention on knowledge. Results: Average 
score of knowledge was 14.18±2.7 (20 max). The educational intervention had a 
significant effect on knowledge scores of the respondents (Wilcoxon rank test p< 
0.005) (considering the pre-intervention knowledge score as zero). Certain demo-
graphic characteristics (academic degree and living status) does affect knowledge 
scores of the study respondents. cOnclusiOns: Although adequate improvement 
of osteoporosis knowledge scores were reported after educational intervention, yet 
efforts should be made to bring change in the attitudes and practices of the female 
student by the help of intensive educational programs based on specified behavioral 
learning theories for better disease knowledge and prevention.
PMs19
Desarrollo De uNa guia De iNterveNcioN Psicologica Para artritis 
reuMatoiDe eN coloMBia
Orozco AM, Méndez-García I, Cabal A, Díaz-Sotelo OD
Universidad El Bosque, Bogotá D.C., Colombia
